News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Integral Diagnostics.
RELATED STOCKHEAD STORIES
Health & Biotech
Broker Upgrades: Whole is greater than the sum, as Jarden urges buying into IDX-CAJ merger
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise as M&A activity heats up
Experts
MoneyTalks: Walk like an Egyptian, but Think like an Acquirer
Experts
SUNDAY ROAST: The stocks that lit a fire under our experts this week
Experts
MoneyTalks: The most irresistible ASX small cap takeover targets in 2024
Health & Biotech
ASX Health Stocks: Neuren up 17pc on DAYBUE sales, Argenica +40pc on Alzheimer’s data
News
10 at 11ish: MC Mining bounces on takeover bid, Block rockets
News
Market Highlights: Big rally on Wall Street, a soft landing scenario, and 5 ASX small caps to watch today
Experts
SUNDAY ROAST: The small caps that lit a fire under Stockhead’s experts this week
Experts
MoneyTalks: Why Goldman recommends these two ASX stocks in the booming diagnostic imaging space
News
ASX Escrow Watch: Rising star WA1 Resources among companies to release shares in November
Escrow Watch
Escrow Watch: Which companies have shares coming out in the new financial year?
News
Closing Bell: The stock formerly known as Hot Rock is up 70% and other great ASX Adventures
News
Trading Places: BGH ups Virtus stake to above 50pc as battle for fertility company escalates
Experts
ScoPo’s Powerplays: Health stocks bounce up and down as markets tumble
Health & Biotech
ASX Health Stocks: Integral goes big in Queensland, Credit Suisse says it’s time to choose between HLS and ACL
News
